Discussion on the spike protein as an engineered prion protein and its implications for neurological disorders.
-
Dr. Kevin McCairn is a retired systems neuroscientist and primate physiologist. • 0:00
-
The spike protein is considered an engineered prion and incapacitation agent. • 1:00
-
Amals and prons are related to protein misfolding disorders in neurological diseases. • 2:34
-
These proteins have a core property of developing a hydrophobic beta sheet core. • 3:31
-
They can trigger misfolding processes in other peptides, making the landscape complex. • 4:01
-
Specific brain regions may be affected by these protein misfolding disorders. • 4:21
Discussion on the potential engineering of the spike protein and its impact on neurological disorders.
-
MRI images showing cordate and thalamic regions, as well as inflammation in the cortex. • 04:40
-
Classification of prion disorders and their microscopic appearance. • 05:49
-
Discovery of specific peptides in neurological disorders, indicating crossover between different disorders. • 06:18
-
Introduction of prion-like concept to classical neurodegenerative disorders. • 07:08
-
Discussion on the spike protein and its potential engineering. • 09:07
Concerns raised about the spike protein in SARS-CoV-2, its potential neuroinvasive and neurotropic effects, and the presence of amalogenic epitopes.
-
SARS-CoV-2 may be a product of biowarfare research, with potential consequences. • 09:35
-
The spike protein contains amalogenic epitopes, raising concerns about its impact on the immune system. • 11:59
-
Nutrifil elastase can cause the spike protein to fragment, spreading epitopes through the body. • 13:23
Discussion on the potential engineering of spike protein as a prion protein, its implications, and concerns regarding the COVID-19 vaccines.
-
The spike protein’s binding onto is significantly longer than previous iterations of SARS and MERS. • 14:15
-
Concerns raised about the molecular structure changes and the origin of the spike protein. • 14:36
-
Research indicating the emergence of anomalous protein structures in the blood circulation due to spike protein exposure. • 15:10
-
Unusual stacking of properties observed, including resistance to enzymatic degradation mechanisms. • 15:39
-
Identification of HIV-like sequences and concerns about their presence in the spike protein. • 16:18
-
Observations of increased cellular damage and emergence of a new variant. • 17:02
-
Distribution of anomalous sequences in COVID-19 vaccines and concerns about their implications. • 18:01
Discussion on excess deaths, potential involvement of spike protein in causing prion-like propagation, and the need to address medical countermeasures industries.
-
Excess deaths not primarily due to COVID, but related to cardiovascular and neurodegenerative diseases. • 18:43
-
Significant increase in all-cause mortality in younger age groups in the past year. • 19:36
-
Hypotheses about spike protein’s involvement in Long COVID and prion-like propagation. • 20:01
-
Call to action for addressing the influence of medical countermeasures industries. • 20:54